Cargando…

Small Molecules—Prospective Novel HCMV Inhibitors

Human cytomegalovirus (HCMV), a member of the betaherpesvirinae, can cause life-threatening diseases. HCMV is globally widespread, with a seroprevalence in adults varying from 50 to 100%. HCMV infection is rarely of significant consequence in immunocompetent individuals. However, although immune con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bogner, Elke, Egorova, Anna, Makarov, Vadim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000834/ https://www.ncbi.nlm.nih.gov/pubmed/33809292 http://dx.doi.org/10.3390/v13030474

Ejemplares similares

Dispirotripiperazine-core compounds, their biological activity with a focus on broad antiviral property, and perspectives in drug design (mini-review)
por: Egorova, Anna, et al.
Publicado: (2021)

HCMV-Mediated Interference of Bortezomib-Induced Apoptosis in Colon Carcinoma Cell Line Caco-2
por: Härtel, Heike, et al.
Publicado: (2021)

HCMV Infection and Apoptosis: How Do Monocytes Survive HCMV Infection?
por: Collins-McMillen, Donna, et al.
Publicado: (2018)

Targeting Non-Replicating Mycobacterium tuberculosis and Latent Infection: Alternatives and Perspectives (Mini-Review)
por: Egorova, Anna, et al.
Publicado: (2021)

Insight for Immunotherapy of HCMV Infection
por: Long, Xinmiao, et al.
Publicado: (2021)

HCMV latency: what regulates the regulators?
por: Elder, Elizabeth, et al.
Publicado: (2019)

Role of Immunogenetics in the Outcome of HCMV Infection: Implications for Ageing
por: Aiello, Anna, et al.
Publicado: (2019)

CARs—A New Perspective to HCMV Treatment
por: Bednar, Christopher, et al.
Publicado: (2021)

HCMV Antivirals and Strategies to Target the Latent Reservoir
por: Perera, Marianne R., et al.
Publicado: (2021)

US28: HCMV’s Swiss Army Knife
por: Krishna, Benjamin A., et al.
Publicado: (2018)

Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes
por: Shibamura, Miho, et al.
Publicado: (2020)

Synthesis and SAR studies on azetidine-containing dipeptides as HCMV inhibitors
por: Pérez-Faginas, Paula, et al.
Publicado: (2011)

Suppressive effects of pterostilbene on human cytomegalovirus (HCMV) infection and HCMV-induced cellular senescence
por: Wang, Sanying, et al.
Publicado: (2022)

Novel microneutralization assay for HCMV using automated data collection and analysis
por: Abai, Anna Maria, et al.
Publicado: (2007)

Understanding HCMV Latency Using Unbiased Proteomic Analyses
por: Poole, Emma, et al.
Publicado: (2020)

Regulation of the MIE Locus During HCMV Latency and Reactivation
por: Dooley, Abigail L., et al.
Publicado: (2020)

Anti-HCMV activity by an irreversible p97 inhibitor LC-1310
por: Wang, Yan, et al.
Publicado: (2021)

Human Cytomegalovirus (HCMV)-infected Astrocytoma Cells Impair the Function of HCMV-specific Cytotoxic T Cells
por: Kim, Jiyeon, et al.
Publicado: (2020)

Pyrrolo[2,3-e]indazole as a novel chemotype for both influenza A virus and pneumococcal neuraminidase inhibitors
por: Egorova, Anna, et al.
Publicado: (2023)

Apoptosis Disorder, a Key Pathogenesis of HCMV-Related Diseases
por: Yu, Zhongjie, et al.
Publicado: (2021)

Using the Nonhuman Primate Model of HCMV to Guide Vaccine Development
por: Deere, Jesse D., et al.
Publicado: (2014)

Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV
por: Perotti, Michela, et al.
Publicado: (2019)

Gene cloning of the human cytomegalovirus (HCMV) antigen reactive with the serum from a HCMV-infected patient.
por: Kim, M. N., et al.
Publicado: (1994)

Single Chain Antibodies Against gp55 of Human Cytomegalovirus (HCMV) for Prophylaxis and Treatment of HCMV Infections
por: Moazen, Bahareh, et al.
Publicado: (2016)

Challenging the Conventional Interpretation of HCMV Seronegativity
por: Waters, Shelley, et al.
Publicado: (2021)

A Viral Pilot for HCMV Navigation?
por: Adler, Barbara
Publicado: (2015)

HCMV Envelope Glycoprotein Diversity Demystified
por: Foglierini, Mathilde, et al.
Publicado: (2019)

Small Molecule Inhibitors of CXCR4
por: Debnath, Bikash, et al.
Publicado: (2013)

Small molecule inhibitors targeting the cancers
por: Liu, Gui‐Hong, et al.
Publicado: (2022)

Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer
por: Berardi, Rossana, et al.
Publicado: (2013)

Alveolar Macrophages Isolated Directly From Human Cytomegalovirus (HCMV)–Seropositive Individuals Are Sites of HCMV Reactivation In Vivo
por: Poole, Emma, et al.
Publicado: (2015)

Variants of HCMV UL18 Sequenced Directly from Clinical Specimens Associate with Antibody and T-Cell Responses to HCMV
por: Waters, Shelley, et al.
Publicado: (2022)

HCMV Reprogramming of Infected Monocyte Survival and Differentiation: A Goldilocks Phenomenon
por: Stevenson, Emily V., et al.
Publicado: (2014)

Battle between Host Immune Cellular Responses and HCMV Immune Evasion
por: Manandhar, Trishna, et al.
Publicado: (2019)

Extended Applications of Small-Molecule Covalent Inhibitors toward Novel Therapeutic Targets
por: Lee, Jesang, et al.
Publicado: (2022)

Divide et impera: An In Silico Screening Targeting HCMV ppUL44 Processivity Factor Homodimerization Identifies Small Molecules Inhibiting Viral Replication
por: Ghassabian, Hanieh, et al.
Publicado: (2021)

ELISPOT assays with pp65 peptides or whole HCMV antigen are reliable predictors of immune control of HCMV infection in seropositive kidney transplant recipients
por: Zavaglio, Federica, et al.
Publicado: (2023)

Glycoengineering of Therapeutic Antibodies with Small Molecule Inhibitors
por: Li, Shasha, et al.
Publicado: (2021)

Small Molecule Inhibitors of Influenza Virus Entry
por: Chen, Zhaoyu, et al.
Publicado: (2021)

The microRNA Transcriptome of Human Cytomegalovirus (HCMV)
por: Meshesha, Mesfin K, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vestldv3jitdi8d2tjmlsfnvoe